OpenAI in Talks with U.S. FDA to Explore AI Use in Drug Evaluation Process

OpenAI has held a series of discussions with officials at the U.S. Food and Drug Administration (FDA) over the potential use of artificial intelligence to streamline parts of the drug evaluation process, according to a report by Wired published Wednesday. The talks mark a significant step toward integrating generative AI tools into one of the [...]The post OpenAI in Talks with U.S. FDA to Explore AI Use in Drug Evaluation Process appeared first on Tekedia.

Read More